Last Updated on December 24, 2023 by The Health Master
The US Food and Drug Administration (USFDA) has given final approval to Glenmark Pharma’s sodium phenylbutyrate tablets USP, 500 mg.
This is the generic version of Buphenyl Tablets, 500 mg, of Horizon Therapeutics, according to a statement from Glenmark Pharma.
The statement said that the tablets will be distributed in the US by Glenmark Pharma Inc., USA.
USFDA gives approval for Glycopyrrolate injection
USFDA gives final approval for Mesalamine extended-release capsules
USFDA gives final approval for Paclitaxel injection
USFDA gives approval to this Blood Cancer therapy
USFDA grants final approval for Micafungin for injection
USFDA gives tentative approval for Valbenazine capsules
IPC clarifies on uniformity of dosage units & impurities in IP 2022
USFDA gives approval for Glycopyrrolate injection
NPPA panel recommends retail price fixation for Atorvastatin and Bempedoic acid
USFDA gives final approval for Mesalamine extended-release capsules
NPPA fixes price of 272 new drugs in the first six months of 2022-23
Govt constitutes 7 member panel to prepare ‘National Drugs Database’
DCGI to SDCs: Accept hard copy of application for registration of Medical Devices
USFDA issues Form 483 with 5 observations to Lupin
IPC introduces draft amendment to microbial contamination in IP 2022
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
